A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

检 索： 期刊全称 刊名关键词 ISSN         高级检索

期刊名称：EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY ISSN： 1064-1297 出版频率： Bi-monthly 出版社： AMER PSYCHOLOGICAL ASSOC, 750 FIRST ST NE, WASHINGTON, USA, DC, 20002-4242   出版社网址： http://www.apa.org/ 期刊网址： http://www.apa.org/journals/pha/ 影响因子： 3.157 (2020年) 1.922(2018年) 2.354(2017年) 2.186(2016年) 2.139(2015年) 2.712(2014年) 2.626(2013年) 2.545 (2012年) 2.577(2011年) 主题范畴： PSYCHOLOGY, BIOLOGICAL;    PSYCHOLOGY, CLINICAL 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal   Experimental and Clinical Psychopharmacology seeks to promote the discipline of psychopharmacology in its fullest diversity. Psychopharmacology necessarily involves behavioral change, psychological processes, or their physiological substrates as one central variable and psychopharmacological agents as a second central variable. Such agents include drugs and medications, as well as chemicals encountered in the workplace or environment. The journal focuses on both basic and applied research and their integration, with the goal of promoting the advancement of psychopharmacological theory and the development of better drug abuse treatments and more effective pharmacotherapeutics. To this end, the journal publishes original descriptive and experimental research involving animals or humans that spans (a) behavioral pharmacology, (b) drug abuse (including its etiology, progression, and behavioral and pharmacological treatment), and (c) controlled clinical trials that aid in understanding of psychological functions or their drug modulation. Theoretical analyses and reviews that critically integrate and advance systematic research in psychopharmacology are also considered. The journal may also occasionally publish innovations highlighting a novel method, result, measure, or theory (along with comments that may be solicited to address the nature of the innovation and to provide contrasting views) and remarks that provide a brief commentary about important empirical or theoretical issues that have not been previously considered. Although case studies are not appropriate, occasional small-sample experiments with special populations may be considered.   Instructions to Authors   Submit manuscripts electronically (.rtf, PDF, or .doc). General correspondence may be directed to Nancy K. Mello, PhD Incoming Editor McLean Hospital Codirector, Alcohol and Drug Abuse Research Center Harvard Medical School 115 Mill Street Belmont, MA 02478-9106 In addition to addresses and phone numbers, authors should supply electronic mail addresses and fax numbers, if available, for potential use by the editorial office and later by the production office. Authors may also be requested to submit an electronic version of their manuscript on diskette. Authors should keep a copy of their manuscript to guard against loss. Masked review policy. Masked reviews are optional, and authors who wish masked reviews must specifically request them when submitting their manuscripts. Each copy of a manuscript to be mask reviewed should include a separate title page with authors' names and affiliations, and these should not appear anywhere else on the manuscript. Footnotes that identify the authors should be typed on a separate page. Authors should make every effort to see that the manuscript itself contains no clues to their identities. Manuscript preparation. Authors should prepare manuscripts according to the Publication Manual of the American Psychological Association (5th ed.). Manuscripts may be copyedited for bias-free language (see chap. 2 of the Publication Manual). Formatting instructions (all copy must be double-spaced) and instructions on the preparation of tables, figures, references, metrics, and abstracts appear in the Manual. See APA's Checklist for Manuscript Submission. Supplemental materials. APA can now place supplementary materials online, which will be available via the journal's Web page as noted above. To submit such materials, please see Supplementing Your Article With Online Material for details. Abstract and Keywords. All manuscripts must include an abstract containing a maximum of 250 words typed on a separate page. After the abstract, please supply up to five keywords or brief phrases. References. References should be listed in alphabetical order. Each listed reference should be cited in text, and each text citation should be listed in the References. Basic formats are as follows: Collins, R. L. (1993). Drinking restraint and risk for alcohol abuse. Experimental and Clinical Psychopharmacology, 1, 44¨C54. Mitchell, T. R., & Larson, J. R., Jr. (1987). People in organizations: An introduction to organizational behavior (3rd ed.). New York: McGraw-Hill. Bjork, R. A. (1989). Retrieval inhibition as an adaptive mechanism in human memory. In H. L. Roediger III & F. I. M. Craik (Eds.), Varieties of memory & consciousness (pp. 309¨C330). Hillsdale, NJ: Erlbaum. Figures. Graphic files are welcome if supplied as Tiff, EPS, or Powerpoint. High-quality printouts or glossies are needed for all figures. The minimum line weight for line art is 0.5 point for optimal printing. When possible, please place symbol legends below the figure instead of to the side. Original color figures can be printed in color provided the author agrees to pay half of the associated production costs. Experimental and Clinical Psychopharmacology publishes manuscripts that fall into one of four categories: Original Research Reports, Reviews of the Literature, Innovations in Psychopharmacology, and Remarks. Innovations in Psychopharmacology is an occasional section that will highlight papers that establish a novel method, a novel result, a novel measure, or a new theory. Commentary may be solicited to address the nature of the innovation and to provide contrasting views. Remarks, another occasional section, is for brief commentary about important aspects of the field that have not been previously addressed or considered. Remarks could address either empirical or theoretical issues. Remarks are expected to be erudite, integrative, substantive, and thoughtful. Permissions. Authors are required to obtain and provide to the editor on final acceptance all necessary permissions to reproduce in print and electronic form any copyrighted work, including, for example, test materials (or portions thereof) and photographs of people. Final files for production should be prepared as outlined in Preparing Your Electronic Files for Production. Publication policies. APA policy prohibits an author from submitting the same manuscript for concurrent consideration by two or more publications. APA's policy regarding posting articles on the Internet may be found at Posting Articles on the Internet. In addition, it is a violation of APA Ethical Principles to publish "as original data, data that have been previously published" (Standard 8.13). As this journal is a primary journal that publishes original material only, APA policy also prohibits publication of any manuscript that has already been published in whole or in substantial part elsewhere. Authors have an obligation to consult journal editors concerning prior publication of any data upon which their article depends. In addition, APA Ethical Principles specify that "after research results are published, psychologists do not withhold data on which their conclusions are based from other competent professionals who seek to verify the substantive claims through reanalysis and who intend to use such data only for that purpose, provided that the confidentiality of the participants can be protected and unless legal rights concerning proprietary data preclude their release" (Standard 8.14). APA expects authors submitting to this journal to adhere to these standards. Specifically, authors of manuscripts submitted to APA journals are expected to have their data available throughout the editorial review process and for at least 5 years after the date of publication. Authors will be required to state in writing that they have complied with APA ethical standards in the treatment of their sample, human or animal, or to describe the details of treatment. A copy of the APA Ethical Principles may be obtained electronically or by writing the APA Ethics Office, 750 First Street, NE, Washington, DC 20002-4242. APA requires authors to reveal any possible conflict of interest in the conduct and reporting of research (e.g., financial interests in a test procedure, funding by pharmaceutical companies for drug research). Authors of accepted manuscripts will be required to transfer copyright to APA. Preparing files for production. If your manuscript is accepted for publication, please follow the guidelines for file formats and naming provided at Preparing Your Electronic Files for Production. If your manuscript was mask reviewed, please ensure that the final version for production includes a byline and full author note for typesetting   Editorial Board   Warren K. Bickel University of Vermont Consulting Editors Robert L. Balster Medical College of Virginia—Virginia Commonwealth University Alan J. Budney University of Vermont Kathleen M. Carroll Yale University School of Medicine Marilyn E. Carroll University of Minnesota, Twin Cities Campus Howard D. Chilcoat Johns Hopkins University Cynthia A. Conklin University of Pittsburgh School of Medicine Thomas E. Eissenberg Virginia Commonwealth University Mark T. Fillmore University of Kentucky Richard W. Foltin New York State Psychiatric Institute Stephen C. Fowler University of Kansas Charles P. France University of Texas Health Science Center at San Antonio Andrew J. Goudie Liverpool University Mark K. Greenwald Wayne State University Stephen J. Heishman National Institute on Drug Abuse, Clinical Pharmacology and Therapeutics Branch Stephen T. Higgins University of Vermont Chris-Ellyn Johanson Wayne State University Thomas H. Kelly University of Kentucky Gregory J. Madden University of Wisconsin¡ªEau Claire Cecile A. Marczinski University of Kentucky G. Alan Marlatt University of Washington, Seattle Lisa A. Marsch National Development and Research Institutes Edward V. Nunes New York State Psychiatric Institute Kenneth A. Perkins University of Pittsburgh, School of Medicine Nancy M. Petry University of Connecticut Health Center Howard Rachlin State University of New York at Stony Brook Damaris J. Rohsenow Brown University Craig R. Rush University of Kentucky Charles Schuster Wayne State University David Shurtleff National Institute on Drug Abuse Kenneth Silverman Johns Hopkins University School of Medicine Roger D. Spealman Harvard Medical School¡ªNERPRC Maxine L. Stitzer Johns Hopkins University Eric C. Strain Johns Hopkins University Stephen T. Tiffany University of Utah School of Medicine Rudy E. Vuchinich University of Alabama at Birmingham Jenny L. Wiley Medical College of Virginia, Virginia Commonwealth University James H. Woods University of Michigan Medical School Alice M. Young Wayne State University